Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
- Status
- RECRUITING
- Phase
- NA
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
- Status
- RECRUITING
- Phase
- NA
Lifestyle-modifying Interventions in Low-risk MDS Patients
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
- Status
- SUSPENDED
- Phase
- PHASE1
Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective，Open-label, Single-arm Study.
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
- Status
- RECRUITING
- Phase
- PHASE2
Cohort Study Assessing the Treatment Strategy for High-Risk Myelodysplastic Syndromes in Patients Under 70
- Status
- UNKNOWN
- Phase
- N/A
A Study of Sabatolimab and Magrolimab-based Treatment in AML or Higher Risk MDS Participants
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts
- Status
- RECRUITING
- Phase
- PHASE2
A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
ACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lymphocytes (TCB008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML)
- Status
- TERMINATED
- Phase
- PHASE2
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
- Status
- RECRUITING
- Phase
- N/A
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
- Status
- RECRUITING
- Phase
- PHASE1
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA